MetLife, Inc. Earnings Recaps
Q2 2026
Aug 8, 2026
MetLife's stock edged up modestly by 1.6%, reflecting steady execution but lacking a clear catalyst to drive stronger investor enthusiasm amid mixed segment performance and cautious outlook signals.
Key takeaways
- Adjusted earnings rose 15% year-over-year to approximately $1.6 billion, with EPS growth at 20%, supported by disciplined capital management.
- Group Benefits segment delivered a 25% increase in adjusted earnings, driven by favorable life underwriting and improved mortality ratios.
- Retirement and Income Solutions saw modest adjusted earnings growth of 2%, with adjusted PFOs rising 19%, highlighting selective capital deployment in global markets.
- Asia operations reported a 21% increase in adjusted earnings (25% on a constant currency basis) and 17% sales growth, led by momentum in Korea and A&H product innovation in Japan.
- Despite integration headwinds from PineBridge Investments raising expenses by ~50 bps, the direct expense ratio held steady at 12.1%, supported by AI-driven productivity gains.
Q1 2026
May 8, 2026
Shares declined 2.6% after earnings as investors appeared cautious despite solid top-line growth and resilient margins, likely reflecting concerns around segments with margin pressures and flat to modestly mixed capital market impacts.
Key takeaways
- Adjusted earnings rose 18% year-over-year to $1.6 billion, with adjusted EPS up 23% reflecting efficient capital management.
- Premiums, fees, and other revenues grew 10%, driven by broad-based growth across nearly all businesses and regions.
- Variable investment income remained strong at $518 million pretax, supported by private equity and venture capital returns.
- Operating margins showed resilience, with a direct expense ratio improving to 11.9% despite integrating PineBridge’s higher-cost structure.
- MetLife Investment Management (MIM) saw a 68% earnings increase following the PineBridge acquisition, although institutional AUM decreased 1.9% sequentially due to market declines.
Q3 2025
Nov 7, 2025
MetLife delivered strong third-quarter results, with adjusted earnings rising 22% year-over-year to $1.6 billion, driven by robust investment margins and operational efficiencies.
Key takeaways
- Adjusted earnings reached $1.6 billion or $2.34 per share, exceeding expectations with strong contributions from variable investment income and volume growth.
- Group Benefits segment reported a 6% increase in adjusted earnings, supported by improved disability and dental profitability.
- Adjusted earnings from Asia surged 36%, bolstered by a 34% rise in sales, particularly strong in Japan.
- MetLife's new Accelerator platform in Latin America has secured over 20 partners, generating $340 million in annualized premiums since launch.
- Adjusted return on equity reached 16.7%, aligning with the company's targets and showcasing the effectiveness of the New Frontier strategy.